Brandon Capital Partners offers short term internships to selected candidates looking to forge a successful career in the life sciences industry.
Working with more than 50 research institutes across Australia and New Zealand which are part of the Medical Research Commercialisation Fund (MRCF) network, interns are generally selected from MRCF members. Interns receive hands-on experience in a venture capital firm, actively working to commercialise ground-breaking research within Australasia.
The internships offer candidates one-on-one learning with Brandon Capital’s investment team, who show interns how to evaluate and identify medical research that has strong commercial potential. Interns are introduced to life sciences venture capital by working on live opportunities that Brandon Capital is evaluating for potential investment.
Through the program, interns are exposed to the commercialisation pathway and what’s necessary to translate medical research into a commercial pharmaceutical or biotech product. Depending on the opportunities at hand and their starting knowledge, interns receive introductions to topics that are important to investors including intellectual property, due diligence, and market analysis, and how that in turn affects the commercialisation process.
Interns also learn about investment decision-making, how venture capitalists make money, and how to pitch research opportunities to potential investors.
Interns are most commonly commercialisation managers, post-docs and (postgraduate) biomedical students wanting to explore the commercial life science world.
Through the internship it was fantastic to understand what Brandon are looking for in the projects they fund. The learnings from the internship program will be applied to the new projects we develop, both in reviewing the opportunity and developing a solid business plan that will increase the commercial success.
The internship was a valuable experience that filled a critical gap in my knowledge of how early-stage life science technologies are commercialised. Up to this point, my experience was from a technology development perspective, and I did not have a full understanding of what investors were seeking in potential investments. The internship experience is immeasurable and will pay dividends well into the future.
The internship was an excellent learning and development opportunity. I greatly improved my understanding of the venture capital financing model and elements such as valuation, due diligence, market analysis and drug development. The MRCF internship program also enabled me to expand my national commercialisation networks and work alongside experienced biotech investors.
